Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.73M Sell
73,897
-11,181
-13% -$491K 0.06% 302
2026
Q1
$4M Buy
85,078
+4,411
+5% +$173K 0.1% 212
2025
Q4
$2.8M Buy
80,667
+6,018
+8% +$211K 0.07% 274
2025
Q3
$2.57M Buy
74,649
+7,357
+11% +$246K 0.07% 287
2025
Q2
$2.01M Buy
67,292
+7,515
+13% +$220K 0.06% 304
2025
Q1
$2.02M Buy
59,777
+17,322
+41% +$565K 0.06% 286
2024
Q4
$1.25M Buy
+42,455
New +$1.28M 0.04% 346

Other funds holding BP

Cary Street Partners's BP Position: Q2 2026 in Review

Cary Street Partners reduced its BP (BP) stake by 13% in Q2 2026, selling an estimated $491K and leaving 73,897 shares worth $2.73M. The position accounts for 0.06% of the portfolio, ranked #302.

Cary Street Partners first reported a position in BP in Q4 2024 and has held it in 7 quarters since. The position peaked at $4M in Q1 2026. 1,162 funds tracked by Wall St. Rank hold BP as of Q2 2026.

  • Cary Street Partners held 73,897 shares of BP worth $2.73M as of Q2 2026.
  • Cary Street Partners sold 11,181 BP shares in Q2 2026, an estimated $491K.
  • BP made up 0.06% of Cary Street Partners's portfolio in Q2 2026, its #302 holding.
  • Cary Street Partners first reported a position in BP in Q4 2024 and has held it in 7 quarters since.
  • Cary Street Partners's BP position peaked at $4M in Q1 2026.
  • 1,162 funds tracked by Wall St. Rank held BP as of Q2 2026.

Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.